These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4049914)

  • 1. Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis.
    Cegalis JA; Possick SG
    Yale J Biol Med; 1985; 58(4):327-36. PubMed ID: 4049914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Integrated treatment of psychosis: combination of psychopharmacology and psychotherapy].
    González de Rivera y Revuelta JL
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1993; 21(3):83-9. PubMed ID: 8333321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative evaluation of clinical and economic effectiveness of preventive therapy of affective and schizoaffective psychoses].
    Ushakov IuV; Kostiukova EG; Kalugina LI; Mirzoian MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):79-82. PubMed ID: 2176049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.
    Tohen M; Castillo J; Pope HG; Herbstein J
    J Clin Psychopharmacol; 1994 Feb; 14(1):67-70. PubMed ID: 8151006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A view from Riggs: treatment resistance and patient authority-IX. Integrative psychodynamic treatment of psychotic disorders.
    Tillman JG
    J Am Acad Psychoanal Dyn Psychiatry; 2008; 36(4):739-61. PubMed ID: 19113964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium.
    Kaschka WP; Thürauf N; Mokrusch T; Korth M
    Pharmacopsychiatry; 1988 Nov; 21(6):404-6. PubMed ID: 3244776
    [No Abstract]   [Full Text] [Related]  

  • 8. Mentalization-based psychodynamic psychotherapy for psychosis.
    Brent B
    J Clin Psychol; 2009 Aug; 65(8):803-14. PubMed ID: 19572277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of inpatient psychiatric and psychotherapeutic treatment of patients with schizophrenia, schizoaffective and other psychotic disorders].
    Leichsenring F; Dumpelmann M; Berger J; Jager U; Rabung S
    Z Psychosom Med Psychother; 2005; 51(1):23-37. PubMed ID: 15834838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Follow-up of psychotic patients. 10 years after inpatient psychiatric-psychotherapeutic treatment].
    Ruff W; Leikert S
    Nervenarzt; 1994 May; 65(5):323-8. PubMed ID: 8052335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preventive treatment of affective psychoses with finlepsin].
    Vovin RIa; Digilov AG; Skorik AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(8):1226-30. PubMed ID: 6495947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of resistant lithium-induced nephrogenic diabetes insipidus and schizoaffective psychosis with carbamazepine.
    Brooks SC; Lessin BE
    Am J Psychiatry; 1983 Aug; 140(8):1077-8. PubMed ID: 6408936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptic infusion and psychotherapy in the intensive care of acute psychiatric patients].
    Elizur A; Levy A; Davidson S
    Harefuah; 1983 Aug; 105(3-4):54-7. PubMed ID: 6140211
    [No Abstract]   [Full Text] [Related]  

  • 14. New developments in the pharmacologic treatment of schizoaffective disorder.
    Keck PE; McElroy SL; Strakowski SM
    J Clin Psychiatry; 1996; 57 Suppl 9():41-8. PubMed ID: 8823349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychoses (schizophrenias)].
    Küchenhoff B; Hell D
    Ther Umsch; 1997 Jul; 54(7):400-4. PubMed ID: 9333991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divalproex sodium in the treatment of refractory affective disorders.
    Schaff MR; Fawcett J; Zajecka JM
    J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing treatment fidelity in psychotherapy research: novel approach to measure the components of cognitive behavioural therapy for relapse prevention in first-episode psychosis.
    Alvarez-Jimenez M; Wade D; Cotton S; Gee D; Pearce T; Crisp K; McGorry PD; Gleeson JF
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1013-20. PubMed ID: 19016089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-episode psychosis: influences of culture and medical comorbidity.
    Donald A; Good B; Forstein M; Beck S
    Harv Rev Psychiatry; 2004; 12(5):279-92. PubMed ID: 15590576
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychosis and the dynamics of the psychotherapy process.
    Rosenbaum B; Harder S
    Int Rev Psychiatry; 2007 Feb; 19(1):13-23. PubMed ID: 17365155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of carbamazepine in the treatment of endogenous psychoses. Results of an open study].
    Azorin JM; Samuelian JC; Pringuey D; Donnet A; Bottai T; Dufour H; Tatossian A
    Encephale; 1986; 12(3):115-9. PubMed ID: 3769857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.